muscular exertion
Recently Published Documents


TOTAL DOCUMENTS

59
(FIVE YEARS 2)

H-INDEX

9
(FIVE YEARS 1)

2019 ◽  
Vol 9 (1) ◽  
pp. 57-61
Author(s):  
Katarzyna Podgorska-Gumulak ◽  
Szymon Suwiczak ◽  
Ewa Szahidewicz-Krupska ◽  
Adrian Doroszko

2019 ◽  
Vol 29 (4) ◽  
pp. 312-318 ◽  
Author(s):  
Takanori Chihara ◽  
Ayana Nozawa ◽  
Akihiko Seo ◽  
Jiro Sakamoto
Keyword(s):  

2017 ◽  
Vol 122 (3) ◽  
pp. 593-602 ◽  
Author(s):  
Yafeng Song ◽  
Shira T. Rosenblum ◽  
Leon Morales ◽  
Mihail Petrov ◽  
Christopher Greer ◽  
...  

Duchenne muscular dystrophy (DMD) is a progressive primary myodegenerative disease caused by a genetic deficiency of the 427-kDa cytoskeletal protein dystrophin. Despite its single-gene etiology, DMD’s complex pathogenesis remains poorly understood, complicating the extrapolation from results of preclinical studies in genetic homologs to the design of informative clinical trials. Here we describe novel phenotypic assays which when applied to the mdx mouse resemble recently used primary end points for DMD clinical trials. By coupling force transduction, high-precision motion tracking, and respiratory measurements, we have achieved a suite of integrative physiological tests that provide novel insights regarding normal and pathological responses to muscular exertion. A common feature of these physiological assays is the precise tracking and analysis of volitional movement, thereby optimizing the relevance to clinical tests. Unexpectedly, the measurable biological distinction between dystrophic and control mice at early time points in the disease process is better resolved with these tests than with the majority of previously used, labor-intensive studies of individual muscle function performed ex vivo. For example, the dramatic loss of volitional movement following a novel, standardized grip test distinguishes control mice from mdx mice by a 17.4-fold difference of the means (3.5 ± 2.2 vs. 60.9 ± 12.1 units of activity, respectively; effect size 1.99). The findings have both mechanistic and translational implications of potential significance to the fields of basic myology and neuromuscular therapeutics. NEW & NOTEWORTHY This study uses novel phenotypic assays which when applied to the mdx mouse resemble recently used primary end points for DMD clinical trials. A measurable distinction between dystrophic and control mice was seen at early time points in vivo compared with invasive muscle studies performed ex vivo. These assays shed light on normal and pathological responses to muscular exertion and have significant mechanistic and translational implications for the fields of basic myology and neuromuscular therapeutics.


2009 ◽  
Vol 149 (2) ◽  
pp. 109-118
Author(s):  
L. KOSTER ◽  
CHR. J. ALERS ◽  
E. H. HAM ◽  
E. WESTREENEN
Keyword(s):  

1998 ◽  
Vol 20 (2) ◽  
pp. 215-233 ◽  
Author(s):  
Glenn Hueckel

The subject of this essay is best introduced by two statements written many years apart. One is by J. S. Mill:[Adam Smith] speaks as if labour were intrinsically the most proper measure of value, on the ground that one day's ordinary muscular exertion of one man, may be looked upon as always, to him, the same amount of effort or sacrifice. But this proposition, whether in itself admissible or not, discards the idea of exchange value altogether, substituting a totally different idea, more analogous to value in use. If a day's labour will purchase in America twice as much of ordinary consumable articles as in England, it seems a vain subtlety to insist on saying that labour is of the same value in both countries, and that it is the value of the other things which is different. Labour, in this case, may be correctly said to be twice as valuable, both in the market and to the labourer himself, in America as in England (Mill, 1909, p. 567).


Sign in / Sign up

Export Citation Format

Share Document